Ranbaxy Recalls Over 64,000 Bottles of Cholesterol Drug

Ranbaxy voluntarily recalled 64,626 bottles of Atorvastatin Calcium 10mg Tablets, the generic version of Pfizer’s Lipitor. This recall was initiated after a pharmacist discovered an Atorvastatin 20mg tablet inside the 10mg bottle.

The affected product is packaged in 90-count bottles with an NDC 63304-827-90 and an expiration date 05/14. This recall has been classified as a Class II recall.  This is Ranbaxy’s second recall regarding Atorvastatin Calcium. In November 2012, Ranbaxy recalled 41 batches of 10mg, 20mg, and 40mg strength tablets due to the concern that some batches contained small glass particles (<1mm).

RELATED: Cardiovascular Disorders Resource Center

Atorvastatin Calcium is a statin indicated as adjunct to a variety of hyperlipoproteinemias including: primary hypercholesterolemia (heterozygous familial and nonfamilial), mixed dyslipidemia, elevated serum triglycerides, primary dysbetalipoproteinemia, and others.

For more information visit FDA.gov.